{"id":687844,"date":"2022-09-22T05:48:14","date_gmt":"2022-09-22T09:48:14","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/ampe-lawsuit-alert-levi-korsinsky-notifies-ampio-pharmaceuticals-inc-investors-of-a-class-action-lawsuit-and-upcoming-deadline-3\/"},"modified":"2022-09-22T05:48:14","modified_gmt":"2022-09-22T09:48:14","slug":"ampe-lawsuit-alert-levi-korsinsky-notifies-ampio-pharmaceuticals-inc-investors-of-a-class-action-lawsuit-and-upcoming-deadline-3","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/ampe-lawsuit-alert-levi-korsinsky-notifies-ampio-pharmaceuticals-inc-investors-of-a-class-action-lawsuit-and-upcoming-deadline-3\/","title":{"rendered":"AMPE LAWSUIT ALERT: Levi &amp; Korsinsky Notifies Ampio Pharmaceuticals, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline"},"content":{"rendered":"<div class=\"xn-newslines\">\n<p class=\"xn-distributor\">PR Newswire<\/p>\n<\/p><\/div>\n<div class=\"xn-content\">\n<p>\n        <span class=\"legendSpanClass\"><br \/>\n          <span class=\"xn-location\">NEW YORK<\/span><br \/>\n        <\/span>, <span class=\"legendSpanClass\"><span class=\"xn-chron\">Sept. 22, 2022<\/span><\/span> \/PRNewswire\/ &#8212;\u00a0Levi &amp; Korsinsky, LLP notifies investors in <b>Ampio Pharmaceuticals, Inc.<\/b> (&#8220;Ampio&#8221; or the &#8220;Company&#8221;) (NYSE: AMPE) of a class action securities lawsuit.<\/p>\n<div class=\"PRN_ImbeddedAssetReference\" id=\"DivAssetPlaceHolder1\">\n<p>\n          <a href=\"https:\/\/mma.prnewswire.com\/media\/1687309\/LK_1920x1080_Logo.html\" target=\"_blank\" rel=\"nofollow noopener\"><br \/>\n            <img decoding=\"async\" src=\"https:\/\/mma.prnewswire.com\/media\/1687309\/LK_1920x1080_Logo.jpg\" title=\"Levi &amp; Korsinsky, LLP (PRNewsfoto\/Levi &amp; Korsinsky, LLP)\" alt=\"Levi &amp; Korsinsky, LLP (PRNewsfoto\/Levi &amp; Korsinsky, LLP)\" \/><br \/>\n          <\/a>\n        <\/p>\n<\/p><\/div>\n<p>\n        <b>CLASS DEFINITION: <\/b>The lawsuit seeks to recover losses on behalf of Ampio investors who were adversely affected by alleged securities fraud. This lawsuit is on behalf of all persons or entities that purchased or otherwise acquired Ampio common stock between <span class=\"xn-chron\">December 29, 2020<\/span> and <span class=\"xn-chron\">August 3, 2022<\/span>, inclusive. Follow the link below to get more information and be contacted by a member of our team:<\/p>\n<p class=\"prntac\">\n        <a href=\"https:\/\/c212.net\/c\/link\/?t=0&amp;l=en&amp;o=3655863-1&amp;h=3743836723&amp;u=https%3A%2F%2Fwww.zlk.com%2Fpslra-1%2Fampio-lawsuit-submission-form%3Fprid%3D32008%26wire%3D4&amp;a=https%3A%2F%2Fwww.zlk.com%2Fpslra-1%2Fampio-lawsuit-submission-form%3Fprid%3D32008%26wire%3D4\" target=\"_blank\" rel=\"nofollow noopener\">https:\/\/www.zlk.com\/pslra-1\/ampio-lawsuit-submission-form?prid=32008&amp;wire=4<\/a>\n      <\/p>\n<p>\n        <b>AMPE<\/b>\u00a0investors may also contact <span class=\"xn-person\">Joseph E. Levi, Esq.<\/span> via email at\u00a0<a href=\"mailto:jlevi@levikorsinsky.com\" target=\"_blank\" rel=\"nofollow noopener\">jlevi@levikorsinsky.com<\/a>\u00a0or by telephone at (212) 363-7500.<\/p>\n<p>\n        <b>CASE DETAILS: <\/b>The filed complaint alleges that defendants made false statements and\/or concealed that: (i) defendants had inflated the Company&#8217;s true ability to successfully file a Biologics License Application (&#8220;BLA&#8221;) for Ampion; (ii) defendants had inflated the results of the AP-013 study and the timing of unblinding the data from the AP-013 study; and (iii) as a result of the foregoing, defendants&#8217; statements about the Company&#8217;s business, operations, and prospects were materially misleading and\/or lacked a reasonable basis.<\/p>\n<p>\n        <b>WHAT&#8217;S NEXT? <\/b>If you suffered a loss in Ampio during the relevant time frame, you have until <b><span class=\"xn-chron\">October 17, 2022<\/span><\/b>\u00a0to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn&#8217;t require that you serve as a lead plaintiff.<\/p>\n<p>\n        <b>NO COST TO YOU: <\/b>If you are a class member, you may be entitled to compensation without payment of any out-of-pocket costs or fees. <b>There is no cost or obligation to participate.<\/b><\/p>\n<p>\n        <b>WHY LEVI &amp; KORSINSKY: <\/b>Over the past 20 years, the team at Levi &amp; Korsinsky has secured hundreds of millions of dollars for aggrieved shareholders and built a track record of winning high-stakes cases. Our firm has extensive expertise representing investors in complex securities litigation and a team of over 70 employees to serve our clients. For seven years in a row, Levi &amp; Korsinsky has ranked in ISS Securities Class Action Services&#8217; Top 50 Report as one of the top securities litigation firms in <span class=\"xn-location\">the United States<\/span>.<\/p>\n<p>\n        <b>CONTACT:<\/b><br \/>\n        <br \/>Levi &amp; Korsinsky, LLP <br \/><span class=\"xn-person\">Joseph E. Levi, Esq.<\/span><br \/><span class=\"xn-person\">Ed Korsinsky, Esq.<\/span><br \/>55 Broadway, 10th Floor<br \/><span class=\"xn-location\">New York, NY<\/span> 10006<br \/><a href=\"mailto:jlevi@levikorsinsky.com\" target=\"_blank\" rel=\"nofollow noopener\">jlevi@levikorsinsky.com<\/a><br \/>Tel: (212) 363-7500<br \/>Fax: (212) 363-7171<br \/><a href=\"https:\/\/c212.net\/c\/link\/?t=0&amp;l=en&amp;o=3655863-1&amp;h=3327283422&amp;u=http%3A%2F%2Fwww.zlk.com&amp;a=www.zlk.com\" target=\"_blank\" rel=\"nofollow noopener\">www.zlk.com<\/a><\/p>\n<div class=\"PRN_ImbeddedAssetReference\" id=\"DivAssetPlaceHolder2\"><\/div>\n<p id=\"PURL\">\n        <img loading=\"lazy\" decoding=\"async\" title=\"Cision\" width=\"12\" height=\"12\" alt=\"Cision\" src=\"https:\/\/c212.net\/c\/img\/favicon.png?sn=NY80762&amp;sd=2022-09-22\" \/> View original content to download multimedia:<a id=\"PRNURL\" rel=\"nofollow noopener\" href=\"https:\/\/www.prnewswire.com\/news-releases\/ampe-lawsuit-alert-levi--korsinsky-notifies-ampio-pharmaceuticals-inc-investors-of-a-class-action-lawsuit-and-upcoming-deadline-301630466.html\" target=\"_blank\">https:\/\/www.prnewswire.com\/news-releases\/ampe-lawsuit-alert-levi&#8211;korsinsky-notifies-ampio-pharmaceuticals-inc-investors-of-a-class-action-lawsuit-and-upcoming-deadline-301630466.html<\/a><\/p>\n<p>SOURCE  Levi &amp; Korsinsky, LLP<\/p>\n<\/p><\/div>\n<p>    <img decoding=\"async\" alt=\"\" src=\"https:\/\/rt.prnewswire.com\/rt.gif?NewsItemId=NY80762&amp;Transmission_Id=202209220545PR_NEWS_USPR_____NY80762&amp;DateId=20220922\" style=\"border:0px;width:1px;height:1px\" \/><\/p>\n","protected":false},"excerpt":{"rendered":"<p>PR Newswire NEW YORK , Sept. 22, 2022 \/PRNewswire\/ &#8212;\u00a0Levi &amp; Korsinsky, LLP notifies investors in Ampio Pharmaceuticals, Inc. (&#8220;Ampio&#8221; or the &#8220;Company&#8221;) (NYSE: AMPE) of a class action securities lawsuit. CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of Ampio investors who were adversely affected by alleged securities fraud. This lawsuit is on behalf of all persons or entities that purchased or otherwise acquired Ampio common stock between December 29, 2020 and August 3, 2022, inclusive. Follow the link below to get more information and be contacted by a member of our team: https:\/\/www.zlk.com\/pslra-1\/ampio-lawsuit-submission-form?prid=32008&amp;wire=4 AMPE\u00a0investors may also contact Joseph E. Levi, Esq. via email at\u00a0jlevi@levikorsinsky.com\u00a0or by telephone at (212) 363-7500. CASE DETAILS: The filed complaint alleges that &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/ampe-lawsuit-alert-levi-korsinsky-notifies-ampio-pharmaceuticals-inc-investors-of-a-class-action-lawsuit-and-upcoming-deadline-3\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;AMPE LAWSUIT ALERT: Levi &amp; Korsinsky Notifies Ampio Pharmaceuticals, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-687844","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.8 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>AMPE LAWSUIT ALERT: Levi &amp; Korsinsky Notifies Ampio Pharmaceuticals, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/ampe-lawsuit-alert-levi-korsinsky-notifies-ampio-pharmaceuticals-inc-investors-of-a-class-action-lawsuit-and-upcoming-deadline-3\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"AMPE LAWSUIT ALERT: Levi &amp; Korsinsky Notifies Ampio Pharmaceuticals, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"PR Newswire NEW YORK , Sept. 22, 2022 \/PRNewswire\/ &#8212;\u00a0Levi &amp; Korsinsky, LLP notifies investors in Ampio Pharmaceuticals, Inc. (&#8220;Ampio&#8221; or the &#8220;Company&#8221;) (NYSE: AMPE) of a class action securities lawsuit. CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of Ampio investors who were adversely affected by alleged securities fraud. This lawsuit is on behalf of all persons or entities that purchased or otherwise acquired Ampio common stock between December 29, 2020 and August 3, 2022, inclusive. Follow the link below to get more information and be contacted by a member of our team: https:\/\/www.zlk.com\/pslra-1\/ampio-lawsuit-submission-form?prid=32008&amp;wire=4 AMPE\u00a0investors may also contact Joseph E. Levi, Esq. via email at\u00a0jlevi@levikorsinsky.com\u00a0or by telephone at (212) 363-7500. CASE DETAILS: The filed complaint alleges that &hellip; Continue reading &quot;AMPE LAWSUIT ALERT: Levi &amp; Korsinsky Notifies Ampio Pharmaceuticals, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/ampe-lawsuit-alert-levi-korsinsky-notifies-ampio-pharmaceuticals-inc-investors-of-a-class-action-lawsuit-and-upcoming-deadline-3\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2022-09-22T09:48:14+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mma.prnewswire.com\/media\/1687309\/LK_1920x1080_Logo.jpg\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/ampe-lawsuit-alert-levi-korsinsky-notifies-ampio-pharmaceuticals-inc-investors-of-a-class-action-lawsuit-and-upcoming-deadline-3\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/ampe-lawsuit-alert-levi-korsinsky-notifies-ampio-pharmaceuticals-inc-investors-of-a-class-action-lawsuit-and-upcoming-deadline-3\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"AMPE LAWSUIT ALERT: Levi &amp; Korsinsky Notifies Ampio Pharmaceuticals, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline\",\"datePublished\":\"2022-09-22T09:48:14+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/ampe-lawsuit-alert-levi-korsinsky-notifies-ampio-pharmaceuticals-inc-investors-of-a-class-action-lawsuit-and-upcoming-deadline-3\\\/\"},\"wordCount\":425,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/ampe-lawsuit-alert-levi-korsinsky-notifies-ampio-pharmaceuticals-inc-investors-of-a-class-action-lawsuit-and-upcoming-deadline-3\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mma.prnewswire.com\\\/media\\\/1687309\\\/LK_1920x1080_Logo.jpg\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/ampe-lawsuit-alert-levi-korsinsky-notifies-ampio-pharmaceuticals-inc-investors-of-a-class-action-lawsuit-and-upcoming-deadline-3\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/ampe-lawsuit-alert-levi-korsinsky-notifies-ampio-pharmaceuticals-inc-investors-of-a-class-action-lawsuit-and-upcoming-deadline-3\\\/\",\"name\":\"AMPE LAWSUIT ALERT: Levi &amp; Korsinsky Notifies Ampio Pharmaceuticals, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/ampe-lawsuit-alert-levi-korsinsky-notifies-ampio-pharmaceuticals-inc-investors-of-a-class-action-lawsuit-and-upcoming-deadline-3\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/ampe-lawsuit-alert-levi-korsinsky-notifies-ampio-pharmaceuticals-inc-investors-of-a-class-action-lawsuit-and-upcoming-deadline-3\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mma.prnewswire.com\\\/media\\\/1687309\\\/LK_1920x1080_Logo.jpg\",\"datePublished\":\"2022-09-22T09:48:14+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/ampe-lawsuit-alert-levi-korsinsky-notifies-ampio-pharmaceuticals-inc-investors-of-a-class-action-lawsuit-and-upcoming-deadline-3\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/ampe-lawsuit-alert-levi-korsinsky-notifies-ampio-pharmaceuticals-inc-investors-of-a-class-action-lawsuit-and-upcoming-deadline-3\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/ampe-lawsuit-alert-levi-korsinsky-notifies-ampio-pharmaceuticals-inc-investors-of-a-class-action-lawsuit-and-upcoming-deadline-3\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mma.prnewswire.com\\\/media\\\/1687309\\\/LK_1920x1080_Logo.jpg\",\"contentUrl\":\"https:\\\/\\\/mma.prnewswire.com\\\/media\\\/1687309\\\/LK_1920x1080_Logo.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/ampe-lawsuit-alert-levi-korsinsky-notifies-ampio-pharmaceuticals-inc-investors-of-a-class-action-lawsuit-and-upcoming-deadline-3\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"AMPE LAWSUIT ALERT: Levi &amp; Korsinsky Notifies Ampio Pharmaceuticals, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"AMPE LAWSUIT ALERT: Levi &amp; Korsinsky Notifies Ampio Pharmaceuticals, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/ampe-lawsuit-alert-levi-korsinsky-notifies-ampio-pharmaceuticals-inc-investors-of-a-class-action-lawsuit-and-upcoming-deadline-3\/","og_locale":"en_US","og_type":"article","og_title":"AMPE LAWSUIT ALERT: Levi &amp; Korsinsky Notifies Ampio Pharmaceuticals, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline - Market Newsdesk","og_description":"PR Newswire NEW YORK , Sept. 22, 2022 \/PRNewswire\/ &#8212;\u00a0Levi &amp; Korsinsky, LLP notifies investors in Ampio Pharmaceuticals, Inc. (&#8220;Ampio&#8221; or the &#8220;Company&#8221;) (NYSE: AMPE) of a class action securities lawsuit. CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of Ampio investors who were adversely affected by alleged securities fraud. This lawsuit is on behalf of all persons or entities that purchased or otherwise acquired Ampio common stock between December 29, 2020 and August 3, 2022, inclusive. Follow the link below to get more information and be contacted by a member of our team: https:\/\/www.zlk.com\/pslra-1\/ampio-lawsuit-submission-form?prid=32008&amp;wire=4 AMPE\u00a0investors may also contact Joseph E. Levi, Esq. via email at\u00a0jlevi@levikorsinsky.com\u00a0or by telephone at (212) 363-7500. CASE DETAILS: The filed complaint alleges that &hellip; Continue reading \"AMPE LAWSUIT ALERT: Levi &amp; Korsinsky Notifies Ampio Pharmaceuticals, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/ampe-lawsuit-alert-levi-korsinsky-notifies-ampio-pharmaceuticals-inc-investors-of-a-class-action-lawsuit-and-upcoming-deadline-3\/","og_site_name":"Market Newsdesk","article_published_time":"2022-09-22T09:48:14+00:00","og_image":[{"url":"https:\/\/mma.prnewswire.com\/media\/1687309\/LK_1920x1080_Logo.jpg","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/ampe-lawsuit-alert-levi-korsinsky-notifies-ampio-pharmaceuticals-inc-investors-of-a-class-action-lawsuit-and-upcoming-deadline-3\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/ampe-lawsuit-alert-levi-korsinsky-notifies-ampio-pharmaceuticals-inc-investors-of-a-class-action-lawsuit-and-upcoming-deadline-3\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"AMPE LAWSUIT ALERT: Levi &amp; Korsinsky Notifies Ampio Pharmaceuticals, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline","datePublished":"2022-09-22T09:48:14+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/ampe-lawsuit-alert-levi-korsinsky-notifies-ampio-pharmaceuticals-inc-investors-of-a-class-action-lawsuit-and-upcoming-deadline-3\/"},"wordCount":425,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/ampe-lawsuit-alert-levi-korsinsky-notifies-ampio-pharmaceuticals-inc-investors-of-a-class-action-lawsuit-and-upcoming-deadline-3\/#primaryimage"},"thumbnailUrl":"https:\/\/mma.prnewswire.com\/media\/1687309\/LK_1920x1080_Logo.jpg","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/ampe-lawsuit-alert-levi-korsinsky-notifies-ampio-pharmaceuticals-inc-investors-of-a-class-action-lawsuit-and-upcoming-deadline-3\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/ampe-lawsuit-alert-levi-korsinsky-notifies-ampio-pharmaceuticals-inc-investors-of-a-class-action-lawsuit-and-upcoming-deadline-3\/","name":"AMPE LAWSUIT ALERT: Levi &amp; Korsinsky Notifies Ampio Pharmaceuticals, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/ampe-lawsuit-alert-levi-korsinsky-notifies-ampio-pharmaceuticals-inc-investors-of-a-class-action-lawsuit-and-upcoming-deadline-3\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/ampe-lawsuit-alert-levi-korsinsky-notifies-ampio-pharmaceuticals-inc-investors-of-a-class-action-lawsuit-and-upcoming-deadline-3\/#primaryimage"},"thumbnailUrl":"https:\/\/mma.prnewswire.com\/media\/1687309\/LK_1920x1080_Logo.jpg","datePublished":"2022-09-22T09:48:14+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/ampe-lawsuit-alert-levi-korsinsky-notifies-ampio-pharmaceuticals-inc-investors-of-a-class-action-lawsuit-and-upcoming-deadline-3\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/ampe-lawsuit-alert-levi-korsinsky-notifies-ampio-pharmaceuticals-inc-investors-of-a-class-action-lawsuit-and-upcoming-deadline-3\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/ampe-lawsuit-alert-levi-korsinsky-notifies-ampio-pharmaceuticals-inc-investors-of-a-class-action-lawsuit-and-upcoming-deadline-3\/#primaryimage","url":"https:\/\/mma.prnewswire.com\/media\/1687309\/LK_1920x1080_Logo.jpg","contentUrl":"https:\/\/mma.prnewswire.com\/media\/1687309\/LK_1920x1080_Logo.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/ampe-lawsuit-alert-levi-korsinsky-notifies-ampio-pharmaceuticals-inc-investors-of-a-class-action-lawsuit-and-upcoming-deadline-3\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"AMPE LAWSUIT ALERT: Levi &amp; Korsinsky Notifies Ampio Pharmaceuticals, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/687844","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=687844"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/687844\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=687844"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=687844"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=687844"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}